Cerium Pharmaceuticals

Funding and NIH signals

• SEC Form D raise Raised $750K (Form D filed Aug 6, 2026). SEC Form D 0001677995-26-000003 (Aug 6, 2026)
  Evidence (1 event)

  • Aug 6, 2026 · SEC Form D 0001677995-26-000003
    Name of Issuer: Cerium Pharmaceuticals, Inc.; CIK: 1677995; Address: Gaithersburg, MD; Submission type: D; Filing date: 2026-08-06; Industry Group: Pharmaceuticals; Date of First Sale: 2026-05-22; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 2544000; Total Amount Sold: 750000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals